A CAR-T therapy used to treat cancer managed to reset the immune system and bring three autoimmune diseases into remission in ...

Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...

Scientists want to know what causes B cells — which direct T cells to attack cancer — to malfunction and how they can be ...

Kylie Jenner, Kim Kardashian, and Chris Hemsworth are publicly embracing stem cell therapy as Hollywood’s newest treatment ...

The stem cell therapy market is witnessing strong growth driven by rising demand for regenerative medicine and advanced treatment options for chronic diseases such as cancer, diabetes, and ...

MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it ...

For the roughly 1.6 million Americans living with type 1 diabetes, the daily calculus of insulin injections, continuous ...

A novel cell therapy is safe and effective in patients with drug-resistant mesial temporal lobe epilepsy and could eventually offer an alternative intervention.

What happened: All 12 trial participants receiving Vertex’s VX-880 therapy began producing insulin, marking a milestone for type 1 diabetes treatment. Why it matters: VX-880 could overcome donor ...

In this retrospective analysis, researchers used real-world data to investigate sex-associated differences in CAR T-cell therapy-related toxicity.

After a surprise rejection at the beginning of 2026, the FDA has agreed to reconsider a T-cell therapy based on the same ...